A case report of endocarditis and spondylitis caused by Brucella melitensis biovar 3

Brucellosis is a worldwide zoonotic disease caused by Brucella spp. Humans can be infected by Brucella mainly through the consumption of unpasteurized dairy products, inhalation of infected aerosolized particles, and close contact with infected animals [1]. Brucella infection causes lesions in multiple organs in the human body. The spleen, liver, testis, bone marrow, and reticuloendothelial cells are the most affected, while cardiovascular and osteoarticular involvements, such as endocarditis, myocarditis, and spondylitis, are rare [2]. A total of 44,036 brucellosis cases occurred in China in 2019 according to the latest data released by the China Centers for Disease Control and Prevention (http://​www.​chinacdc.​cn). The Xinjiang Uygur Autonomous Region (XUAR) is one of the leading pastoral areas in China, which is also an epidemic area with high morbidity due to brucellosis [3]. However, only a few studies regarding endocarditis and spondylitis attributable to Brucella have been reported in China, especially in remote regions. This study focuses on a patient living in the XUAR who suffered from brucellosis-related endocarditis (BE) and spondylitis (BS). The manifestations in this patient are described, and the genetic characteristics of the pathogenic agent are analyzed.

A 55-year-old male shepherd without preexisting diseases began to experience an intermittent fever up to 38–39 °C and back pain on July 1, 2018. The patient was started on oral cephalosporin for 3 months (self-administered), but his symptoms persisted. The patient was sent to the First Affiliated Hospital of Shihezi University with a normal body temperature at 36.6 °C, where he underwent transthoracic echocardiography (TTE) on October 11, 2018. Vegetation (0.7 × 1.5 cm) was discovered on the posterior leaflet of the mitral valve by a TTE examination (Fig. 1a), which caused a mild regurgitation. The serum tube agglutination test (SAT) for Brucella was positive with a titer of 1:800, but the culture result was negative. The blood test results showed that the hemoglobin levels were reduced to 120 g/L (see Additional file 1). The levels of platelets, RBC, and albumin were lower than the normal range. However, the levels of globulin and erythrocyte sedimentation rate (ESR) were higher than the normal range (see Additional file 1). A combination of treatment with doxycycline (200 mg/day) and rifampicin (900 mg/day) was administered to the patient. However, the clinical symptoms were not relieved, and the patient was experiencing a serious backache. The MRI examination revealed that a cold abscess had formed on both sides of the psoas major muscles and the left side of the erector spinae muscle (Fig. 2a), and the CT results indicated hyperplasia of the second and third vertebra (Fig. 2c) on October 15, 2018. The MRI showed a low signal intensity on the T1-weighted images and a high signal intensity on the T2-weighted images of the second and third vertebra. Because of financial constraints, the patient refused to undergo surgical treatment. Hence, he was prescribed oral doxycycline (100 mg/dose, twice a day) and rifampicin (600 mg/dose, once daily) as recommended by the World Health Organization.

Because of a lack of timely medical follow-up, on November 6, 2018, the patient’s condition deteriorated, the size of the vegetation increased to 0.8 × 2.5 cm (Fig. 1b) along with a hemorrhage that occurred on the gingiva, and a hemorrhagic spot formed on both lower limbs. An echocardiogram confirmed the presence of severe regurgitation. Additionally, the left atrium and ventricle were enlarged, and the left ventricular ejection fraction was 64%. The blood test results showed that the platelet level dropped rapidly over time, reaching its lowest level at 29 × 10⁹/L on November 6, 2018 (see Additional file 1). The MRI examination showed that both the second and third vertebra hyperplasia and abscess in the muscle increased significantly on November 19, 2018 (Fig. 2b, d). The antibiotics for brucellosis were changed to levofloxacin (400 mg/dose, once daily), doxycycline (100 mg/dose, twice a day), and sulfamethoxazole tablets (600 mg/dose, once daily), and the patient was treated with medicines to enhance the platelet levels at the same time.

However, the patient’s situation deteriorated again, and heart failure was discovered on October 22, 2019. The size of the vegetation was 1.3 × 1.5 cm (Fig. 1c). The left atrium and ventricle were further enlarged, and the left ventricular ejection fraction was 58%. The end-diastolic volume (EDV) and end-systolic volume (ESV) of the left ventricular were 304 ml and 105 ml, respectively. A strong regurgitation signal presented on the mitral valve, with a pulse rate of 67 beats/min. The fraction shortening (FS) value was 36%. Although the platelet level had recovered to 52 × 10⁹/L, the hemoglobin level sharply decreased to 85 g/L (see Additional file 1). The NT-proBNP levels reached 4152.0 pg/mL, 33 times higher than the normal level. It is worth noting that the level of creatinine was normal, except on October 22, 2019, when it reached its peak level at 252.6 umol/L (see Additional file 1). Additionally, the bone marrow aspiration result showed that the proliferation of bone marrow was considerably reduced, the granulocyte and erythrocytes were multiplicative, and the proportion of neutrophilic segmented granulocytes increased with the development of granulocyte lineage hyperplasia in the bone marrow (data not shown). At the moment of submission of this manuscript, the patient remains in bed at home because of severe debility caused by brucellosis. Now, the patient must undergo regular renal dialysis as a follow-up, and on June 26, 2020, the patient had renal dialysis. The clinical symptoms and diagnostic results at different times are listed in Additional file 1. The onset, diagnosis, and treatment of the disease in this patient are shown in Fig. 3.

Brucellosis is a worldwide zoonosis and systemic disease. The transmission to humans occurs primarily through contact with infected animals or the consumption of contaminated food such as raw milk and its byproduct [9]. Brucella infection cause lesions in any organ and system in the human body. The clinical symptoms of brucellosis include intermittent fever, night sweats, and joint and muscle pain [10]. The complications caused by brucellosis include osteoarticular, epididymal orchitis, nervous disorders, and liver involvement [11]. However, endocarditis combined spondylitis caused by Brucella is rarely reported. The incidence rate of endocarditis accounts for approximately only 2% of all brucellosis cases, but it is responsible for 80% of brucellosis-related mortality [12]. Jia et al. [13] studied 10 BE cases and discovered a high death rate without the replacement of valves. In contrast, all of those who accepted prosthetic valve replacement surgery combined with at least 6 weeks of drug treatment survived and showed no relapse. Dourakis et al. [14] found that the implantation of the defibrillator itself could induce a case of BE. The patient recovered after the defibrillator was removed, and the pacemaker was explanted. In addition, the large vegetation was removed through surgery. Mahjoub et al. [15] studied infective endocarditis caused by Brucella. The patient showed a good prognosis after receiving a high dose of antibiotics and underwent surgery with mitral valve replacement. It has been reported that the mortality rate of BE treated with a combination of antibiotics and surgery was 6.7%, whereas that with antibiotic treatment only was 32.7% [16]. In our case report, the patient suffered brucellosis-induced endocarditis and spondylitis. However, because of financial constraints, the patient refused to undergo surgical treatment that might have improved his condition. Intriguingly, vegetation has been found in most BE cases. It has been reported that Brucella can often cause valvular lesions and cardiac insufficiency [17]. The reason why Brucella can cause vegetation on the valve is unknown.

Brucellosis can affect the entire vertebral column, and the lumbar spine is the most frequently involved vertebral region, followed by the thoracic and cervical segments [18, 19]. It is well known that the multiple and contagious involvement of vertebral bodies occurs in tuberculous spondylodiscitis [20]. However, Brucella’s involvement in numerous vertebral bodies has been described in only 9–20% cases [21]. The infection not only affects the vertebrae but also causes damage to neighboring tissues, including epidural and para-prevertebral tissues, psoas muscles, and radicles. Ulu-Kilic and colleagues [18] studied 293 patients with spinal brucellosis in Turkey, and psoas abscess only accounted for 3.4% (10) patients. In this study, hyperplasia occurred on the patient’s second and third centrum, and a cold abscess formed on both sides of the psoas major muscles and the left side of erector spinae muscle. The thick abscess that formed in the psoas and spinae muscle suggested complicated BS according to the definitions [18].

The most common manifestations among BE or patients with BS are fever, sweating, backache, debility, spleen, and liver enlargement [17, 18]. In this study, in addition to the symptoms mentioned previously, the patient suffered a hemorrhage on the gingiva, a hemorrhagic spot formed on the lower limbs, and even edema appeared when heart failure was discovered on October 22, 2019. Very few studies have reported such clinical symptoms before. Hence, it could be an atypical manifestation for the patient who suffered BE combined with BS.

B. abortus and B. melitensis are the most frequently isolated species from BE patients, but Brucella suis is rarely found (5% of cases) [15, 17, 22, 23]. B. melitensis causes more severe diseases associated with disabling complications [24]. Of note, B. melitensis is also the most predominant pathogen isolated from BS cases, with 61% biovar 3 isolates and 39% biovar 1 isolate [18, 25‐27]. In this study, the organism was also identified as B. melitensis biovar 3, and this was consistent with previous studies where human and livestock brucellosis were primarily caused by B. melitensis biovar 3 in XUAR [5, 28]. Interestingly, the Brucella isolates in this study closely matched the B. melitensis biovar 3 isolated from the Asia badger, which indicates that the Asia badger is a Brucella spillover host that infects sheep or cattle and then acts as a reservoir host, and this poses a massive threat to livestock and humans [8].

For those with brucellosis endocarditis and spondylitis, drug treatment combined with surgery is the best approach, especially for patients with severe endocarditis and spondylitis. However, surgery is the last option for treating BS [29]. Maryam [16] reported that the mortality rate of BE with drugs combined with surgical treatment was 6.7%, but the drug treatment solely was 32.7%. There is no consensus for treating BE and BS. Patients are typically given doxycycline and rifampicin with or without aminoglycoside [30, 31].

Alternatively, it has been reported that streptomycin combined with doxycycline has superior efficacy and lower relapse rates than other treatments [27, 32]. The duration of antibiotic therapy in patients is adjusted according to the clinical manifestation. In addition, financial constraints, health care system-related differences, and follow-up are important factors that affect a patient’s treatment. In this study, the patient was not a local resident and his medical insurance did not cover the Shihezi health care system. Hence, the local government could only provide a partial subsidy for the patient’s medical costs according to health care system regulations. However, the patient still refused to undergo surgery due to financial constraints. In addition, timely follow-up was not able to be obtained, which might be another reason for the deterioration of the patient’s condition. These situations may be present for some patients; hence, they cannot be ignored in the treatment.